Because traditional FAK kinase domain inhibitors have limited effects on cancer cell apoptosis12,13 but disruption of the FAT domain induces apoptosis17–19, we next tested lead FAT inhibitor 2012 in annexin V apoptosis assays. Here, ANXA5 is linked to cancer.